Charles River Laboratories | CRL - EPS Earnings Per Share


Charles River Laboratories reported $2.06 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 2.06 1.93 2.34 May/07
FY2025Q4 Dec/2025 2.39 2.35 2.66 Feb/18
FY2025Q3 Sep/2025 2.43 2.34 2.59 Nov/05
FY2025Q2 Jun/2025 3.12 2.48 2.80 Aug/06
FY2025Q1 Mar/2025 2.34 2.13 2.27 May/07




Eps Change Date
Agilent USD 1.43 0.11 Mar/2026
Align Technology USD 2.58 0.71 Mar/2026
Bio-Rad Laboratories USD 1.89 0.62 Mar/2026
Bruker USD 0.31 0.28 Mar/2026
Cardinal Health USD 3.17 0.54 Mar/2026
Charles River Laboratories USD 2.06 0.33 Mar/2026
Cigna USD 7.79 0.29 Mar/2026
Concord Medical Services Hldg CNY -0.21 0.49 Jun/2025
CVS Health USD 2.57 1.48 Mar/2026
Danaher USD 2.06 0.17 Mar/2026
Dentsply International USD 0.27 0.2 Mar/2026
Elevance Health USD 12.58 9.25 Mar/2026
Humana USD 10.31 14.27 Mar/2026
Illumina USD 1.15 0.2 Mar/2026
Incyte USD 1.81 0.01 Mar/2026
Intrexon USD -0.1 0.03 Jun/2024
IQVIA Holdings USD 2.9 0.52 Mar/2026
Laboratory Of America USD 4.25 0.18 Mar/2026
Lakefront Biotherapeutics EUR -0.84 12.73 Mar/2026
Lonza CHF 6.07 1.92 Jun/2025
McKesson USD 11.69 2.35 Mar/2026
Merck EUR 2.11 0.23 Mar/2026
Mettler Toledo International USD 8.91 4.45 Mar/2026
Novartis USD 1.99 0.04 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
Quest Diagnostics USD 2.5 0.08 Mar/2026
Revvity USD 1.06 0.64 Mar/2026
Thermo Fisher Scientific USD 5.44 1.13 Mar/2026
United Therapeutics USD 5.82 1.88 Mar/2026
UnitedHealth USD 7.23 5.12 Mar/2026
Veradigm USD -0.34 0.46 Dec/2022
Waters USD 2.7 1.83 Mar/2026
West Pharmaceutical Services USD 2.13 0.09 Mar/2026